(Q51279189)

2 April 2018

title

Narcotic antagonist treatment: clinical experience with naltrexone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A730406

23 July 2022

0 references

D. C. Lewis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A730406

23 July 2022

J. Mayer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A730406

23 July 2022

R. G. Hersch

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A730406

23 July 2022

R. Black

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A730406

23 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=730406

23 July 2022

publication date

1 August 1978

1 reference

2 April 2018

published in

Substance Use and Misuse

1 reference

2 April 2018

volume

13

1 reference

2 April 2018

issue

6

1 reference

2 April 2018

page(s)

961-973

1 reference

2 April 2018

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F10826087809039316

A behavioral paradigm for the evaluation of narcotic antagonists

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F10826087809039316

Clinical Experience with Naltrexone

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F10826087809039316

10.3109/10826087809039316

21 January 2018

Identifiers

DOI

1 reference

2 April 2018

1 reference

2 April 2018